Bazedoxifene and conjugated estrogens may offer a safer, more effective alternative to tamoxifen for overweight women at high ...

Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider ...

The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

A California biotech company has developed a new pill that could extend a dog’s life. After one year of the groundbreaking clinical trial, the pill cleared a major FDA hurdle. More than 1,000 ...

India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, due to safety concerns. These combinations were manufactured and sold ...

Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.

A new experimental GLP-1 drug, in pill form, could transform the weight loss drug boom. Eli Lilly's new experimental pill called orforglipron, helped patients shed weight and control blood sugar ...

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly’s new obesity and diabetes pill has shown it can lower blood sugar and aid weight loss in a late-stage trial, sending shares in the US drugmaker up nearly 15 per cent in Wall Street ...

(KOIN) – A Portland drug trafficker was sentenced to federal prison on Wednesday on several drug trafficking charges after authorities found him in possession of more than 50,000 fentanyl pills ...

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective in treating obesity and diabetes. The drug, developed by Eli Lilly and ...